These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 15530848)
1. Reactive oxygen species mediate RANK signaling in osteoclasts. Ha H; Kwak HB; Lee SW; Jin HM; Kim HM; Kim HH; Lee ZH Exp Cell Res; 2004 Dec; 301(2):119-27. PubMed ID: 15530848 [TBL] [Abstract][Full Text] [Related]
2. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH. Kwak HB; Lee SW; Li YJ; Kim YA; Han SY; Jhon GJ; Kim HH; Lee ZH Biochem Pharmacol; 2004 Apr; 67(7):1239-48. PubMed ID: 15013839 [TBL] [Abstract][Full Text] [Related]
5. Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production. Yip KH; Zheng MH; Steer JH; Giardina TM; Han R; Lo SZ; Bakker AJ; Cassady AI; Joyce DA; Xu J J Bone Miner Res; 2005 Aug; 20(8):1462-71. PubMed ID: 16007343 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759 [TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Hu JP; Nishishita K; Sakai E; Yoshida H; Kato Y; Tsukuba T; Okamoto K Eur J Pharmacol; 2008 Feb; 580(1-2):70-9. PubMed ID: 18083161 [TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232 [TBL] [Abstract][Full Text] [Related]
9. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation. Ichikawa H; Murakami A; Aggarwal BB Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641 [TBL] [Abstract][Full Text] [Related]
10. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption. Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068 [TBL] [Abstract][Full Text] [Related]
11. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Shishodia S; Aggarwal BB Oncogene; 2006 Mar; 25(10):1463-73. PubMed ID: 16331273 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1). Kwak HB; Jin HM; Ha H; Kang MJ; Lee SB; Kim HH; Lee ZH Biochem Biophys Res Commun; 2005 May; 330(4):1080-6. PubMed ID: 15823554 [TBL] [Abstract][Full Text] [Related]
13. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114 [TBL] [Abstract][Full Text] [Related]
15. Evidence of reciprocal regulation between the high extracellular calcium and RANKL signal transduction pathways in RAW cell derived osteoclasts. Xu J; Wang C; Han R; Pavlos N; Phan T; Steer JH; Bakker AJ; Joyce DA; Zheng MH J Cell Physiol; 2005 Feb; 202(2):554-62. PubMed ID: 15389575 [TBL] [Abstract][Full Text] [Related]
16. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Wada T; Nakashima T; Oliveira-dos-Santos AJ; Gasser J; Hara H; Schett G; Penninger JM Nat Med; 2005 Apr; 11(4):394-9. PubMed ID: 15750601 [TBL] [Abstract][Full Text] [Related]
17. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627 [TBL] [Abstract][Full Text] [Related]
18. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Tanaka S; Nakamura K; Takahasi N; Suda T Immunol Rev; 2005 Dec; 208():30-49. PubMed ID: 16313339 [TBL] [Abstract][Full Text] [Related]
19. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166 [TBL] [Abstract][Full Text] [Related]